CORREVIO PHARMA CORP's ticker is CORV and the CUSIP is 22026V105. A total of 23 filers reported holding CORREVIO PHARMA CORP in Q2 2018. The put-call ratio across all filers is - and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2019 | $2,400,000 | -7.4% | 1,200,000 | 0.0% | 0.10% | +2.1% |
| Q2 2019 | $2,592,000 | -31.6% | 1,200,000 | 0.0% | 0.09% | -35.6% |
| Q1 2019 | $3,792,000 | +26.9% | 1,200,000 | 0.0% | 0.15% | +3.5% |
| Q4 2018 | $2,988,000 | -38.1% | 1,200,000 | 0.0% | 0.14% | -19.4% |
| Q3 2018 | $4,824,000 | +6.3% | 1,200,000 | 0.0% | 0.18% | 0.0% |
| Q2 2018 | $4,536,000 | – | 1,200,000 | – | 0.18% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Stonepine Capital Management, LLC | 1,930,022 | $7,295,000 | 4.43% |
| Tamarack Advisers, LP | 2,000,000 | $7,560,000 | 2.53% |
| CLOUGH CAPITAL PARTNERS L P | 2,062,263 | $7,795,000 | 0.70% |
| Rock Springs Capital Management LP | 1,200,000 | $4,536,000 | 0.18% |
| WESTFIELD CAPITAL MANAGEMENT CO LP | 4,627,954 | $17,494,000 | 0.13% |
| PUTNAM INVESTMENTS LLC | 6,184,266 | $23,376,000 | 0.03% |
| Renaissance Technologies | 605,423 | $2,288,000 | 0.00% |
| DEUTSCHE BANK AG\ | 32,600 | $123,000 | 0.00% |
| MORGAN STANLEY | 22,025 | $82,000 | 0.00% |
| BANK OF MONTREAL /CAN/ | 504 | $2,000 | 0.00% |